Analysis revealed that patients with T-cell exhausted archetype tumors had significantly higher rates of progressive disease ...

In CAR T-cell therapy for diffuse large B-cell lymphoma, distinct archetypes could guide personalized treatment decisions.

The blood cancer multiple myeloma is deadly. This disease is personal for us because one of our best friends and colleagues ...

Jacob E. Berchuck, MD, discusses research on plasma epigenomic profiling in metastatic castration-resistant prostate cancer.

The released batch was manufactured at Everest's Jiashan manufacturing site using the Company's proprietary mRNA platform, in compliance with global GMP standards. EVM14 is an off-the-shelf ...

T cells are a promising cancer therapy that are made from the patient's own T cells, which are reprogrammed to fight their ...

Chimeric antigen receptor (CAR)-T cells are a promising cancer therapy that are made from the patient's own T cells, which ...

In India, two cancer patients treated with CAR T therapy have survived three years in one of the longest follow-ups in South ...

Glioblastoma has been deadly and hard to treat, but researchers say they’ve made progress with bivalent CAR T-cell therapy ...

Mr Sherry added his wife had told him: "No mammy should have to be away from their children." He has called for a more joined ...

In a landmark development for cancer care in India and for Chimeric Antigen Receptor T-cell (CAR T) therapy, two patients in Bengaluru have completed three years of successful follow-up, one of the ...